AI Insight
The human body develops from approximately 100 embryonic stem cells that give rise to all 30 trillion cells found in the adult organism. These embryonic stem cells are classified as pluripotent due to their capacity to differentiate into any cell type in the body. Researchers are currently investigating ways to harness this pluripotency for therapeutic applications, including potential treatments for diabetes.
Why it matters
The ability to direct stem cell differentiation toward specific cell types, such as insulin-producing pancreatic beta cells, could offer new treatment avenues for diabetic patients who currently rely on lifelong medication or insulin therapy.
Humans have around 30 trillion cells in our adult bodies. Amazingly, each of these cells came from a handful of about 100 stem cells in the earliest days of development. The ability of these embryonic stem cells to turn into any cell type makes them pluripotent—something that researchers are harnessing in science and medicine today.
Source: Stem cells have potent potential for diabetes treatment